IntraOp Medical Corporation
IntraOp Medical Corporation, headquartered in the United States, is a pioneering force in the medical technology industry, specialising in innovative intraoperative radiation therapy (IORT) solutions. Founded in 2005, the company has made significant strides in enhancing cancer treatment through its flagship product, the Mobetron, which delivers targeted radiation directly to tumours during surgery, minimising damage to surrounding healthy tissue. With a strong presence in North America and expanding operations in Europe, IntraOp Medical has established itself as a leader in the field of cancer care. The company's commitment to advancing surgical oncology has garnered recognition, positioning it at the forefront of IORT technology. By integrating cutting-edge engineering with clinical expertise, IntraOp continues to redefine standards in patient care and improve outcomes for cancer patients worldwide.
DitchCarbon Score
How does IntraOp Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
IntraOp Medical Corporation's score of 23 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
IntraOp Medical Corporation's reported carbon emissions
IntraOp Medical Corporation, headquartered in the US, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. Furthermore, there are no documented reduction targets or climate pledges outlined by the company at this time. This lack of information suggests that IntraOp may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it will be essential for IntraOp Medical Corporation to establish clear commitments and measurable targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
IntraOp Medical Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
